{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-075826","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2026-06-18T21:00:51+00:00","discovered_at":"2026-06-18T21:02:00.312010+00:00","generated_at":"2026-06-18T21:02:25.891066+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Shareholders approve amended equity plan at annual meeting, re-elect directors","bullets":["Amended 2023 Equity Incentive Plan approved: 38.9M for, 17.4M against, 18.3M broker non-votes.","Plan share reserve set at 9,594,213; annual evergreen increase of 5% of outstanding shares through 2029.","All eight director nominees elected; Jennifer Jarrett (16.5M against) and Amit Munshi (16.0M against) had notable opposition.","Ratification of WithumSmith+Brown, PC as auditor for FY2026 passed with 74.3M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-075826","json":"https://secwatch.observer/filing/0001104659-26-075826.json","markdown":"https://secwatch.observer/filing/0001104659-26-075826.md","text":"https://secwatch.observer/filing/0001104659-26-075826.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/0001104659-26-075826-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/tm2618327d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T21:02:25.891066+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e68f03a9d77be66c8ce7662bd0070c7ac97a3da","claim":"Zura Bio Ltd shareholders approved Ratification of the appointment of WithumSmith+Brown, PC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 2 - Ratification of the Appointment of Independent Registered Public Accounting Firm. The Company's shareholders ratified the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes cast were as follows: For Against Abstain 74,323,697 30,527 193,928","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/0001104659-26-075826-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"481bacd9573cdd78cd1e828e4eba205c3e8d2398","claim":"Zura Bio Ltd shareholders approved Approval of the Amended and Restated 2023 Zura Bio Limited Equity Incentive Plan at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 3 - Approval of the Amended and Restated 2023 Zura Bio Limited Equity Incentive Plan The Company's shareholders approved the amendment and restatement of the Company's 2023 Equity Incentive Plan. The votes cast were as follows: For Against Abstain Broker Non-Votes 38,850,373 17,403,607 26,663 18,267,509","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/0001104659-26-075826-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"f0742c15621531027c01d394a2747264f61781c8","claim":"Zura Bio Ltd shareholders approved Election of eight director nominees at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 1 - Election of Directors. The Company's shareholders elected the Director Nominees as directors of the Company, each to hold office until the next annual general meeting of shareholders or until their respective successors have been elected and qualified, or until their earlier death, resignation or removal. The votes cast were as follows: Nominee For Against Abstain Broker Non-Votes Daniel Becker 55,968,512 291,173 20,958 18,267,509 Mark Eisner 56,209,068 49,466 22,109 18,267,509 Jennifer Jarrett 39,788,639 16,471,044 20,958 18,267,511 Sandeep Kulkarni 56,250,391 8,292 21,960 18,267,509 Amit Munshi 40,229,829 16,027,697 23,115 18,267,511 Ajay Nirula 56,249,212 8,319 23,113 18,267,508 Steven Schoch 56,197,526 61,025 22,093 18,267,508 Parvinder Thiara 55,766,669 490,857 23,115 18,267,511","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/0001104659-26-075826-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}